• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep Med . Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patien

tetano

Editor, Senior Moderator
Cell Rep Med


. 2020 Nov 3;1(8):100130.
doi: 10.1016/j.xcrm.2020.100130. eCollection 2020 Nov 17.
Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients


Teresa Aydillo[SUP] 1 2 [/SUP], Alba Escalera[SUP] 1 2 [/SUP], Shirin Strohmeier[SUP] 1 [/SUP], Sadaf Aslam[SUP] 1 2 [/SUP], Javier Sanchez-Cespedes[SUP] 3 4 [/SUP], Juan Ayllon[SUP] 1 2 [/SUP], Cristina Roca-Oporto[SUP] 3 4 [/SUP], Pilar Perez-Romero[SUP] 5 4 [/SUP], Miguel Montejo[SUP] 6 4 [/SUP], Joan Gavalda[SUP] 7 4 [/SUP], Patricia Munoz[SUP] 8 4 [/SUP], Francisco Lopez-Medrano[SUP] 9 4 [/SUP], Jordi Carratala[SUP] 10 4 [/SUP], Florian Krammer[SUP] 1 [/SUP], Adolfo Garc?a-Sastre[SUP] 1 2 11 12 [/SUP], Elisa Cordero[SUP] 3 13 4 [/SUP]



Affiliations
Free PMC article

Abstract

Hemagglutination-inhibitory antibodies are usually highly strain specific with little effect on infection with drifted or shifted strains. The significance of broadly cross-reactive non-HAI anti-influenza antibodies against conserved domains of virus glycoproteins, such as the hemagglutinin (HA) stalk, is of great interest. We characterize a cohort of 40 H1N1pmd09 influenza-infected patients and identify lower respiratory symptoms (LRSs) as a predictor for development of pneumonia. A binomial logistic regression of log10 pre-existing antibody values shows that the probability of LRS occurrence decreased with increased anti-HA full-length and stalk antibody ELISA titers. However, a multilevel logistic regression model adjusted by other potential serocorrelates demonstrates that only antibodies directed against the stalk of HA correlate with protection from lower respiratory infection, limiting disease progression. Our predictive model indicates that a threshold of protective immunity based on broadly cross-reactive HA stalk antibodies could be feasible.

Keywords: correlates of protection; influenza antibodies; transplant patients; viral pneumonia.
 
Back
Top Bottom